Listed

Amneal Pharmaceuticals, Inc.

AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31

Reports and events: 191 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amneal Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2019-08-0516:39 ET10-QQuarterly reportPeriod 2019-06-300001723128-19-000111
2019-08-0506:20 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-19-000107
2019-08-0506:13 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-19-000105
2019-07-1916:51 ETSC 13D/AOwnership report, active investor, amended0001387131-19-005210
2019-07-1016:52 ET8-K2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-19-000100
2019-05-0916:43 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001723128-19-000081
2019-05-0916:16 ET10-QQuarterly reportPeriod 2019-03-310001723128-19-000079
2019-05-0906:42 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-19-000076
2019-03-2216:19 ETDEF 14AProxy statementPeriod 2019-05-060001308179-19-000058
2019-03-0108:55 ET8-K/A9.01 Financial statements and exhibits0001193125-19-059421
2019-03-0108:31 ET10-KAnnual reportPeriod 2018-12-310001723128-19-000028
2019-02-2808:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-19-000023
2019-01-2416:25 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001723128-19-000017
2019-01-0809:14 ET8-K7.01 Regulation FD disclosure0001723128-19-000011
2019-01-0716:23 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001723128-19-000005
2018-12-0716:24 ET8-K8.01 Other events0001723128-18-000039
2018-11-0716:51 ET10-QQuarterly reportPeriod 2018-09-300001723128-18-000037
2018-11-0707:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-18-000035
2018-08-0916:49 ET10-QQuarterly reportPeriod 2018-06-300001723128-18-000030
2018-08-0907:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-18-000027
2018-07-1219:25 ET8-K/A9.01 Financial statements and exhibits0001723128-18-000024
2018-07-0917:17 ETSC 13DOwnership report, active investor0001193125-18-214805
2018-07-0917:15 ETSC 13D/AOwnership report, active investor, amended0001193125-18-214801
2018-07-0917:12 ETSC 13DOwnership report, active investor0001193125-18-214798
2018-07-0917:11 ETSC 13DOwnership report, active investor0001193125-18-214797
2018-07-0917:09 ETSC 13DOwnership report, active investor0001193125-18-214792
2018-07-0917:07 ETSC 13DOwnership report, active investor0001193125-18-214788
2018-06-0716:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-186843
2018-05-2108:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-18-000019
2018-05-1616:42 ET8-K2.05 Exit or disposal costs0001723128-18-000016
2018-05-1516:43 ET10-QQuarterly reportPeriod 2018-03-310001723128-18-000013
2018-05-1416:30 ETSC 13DOwnership report, active investor0001193125-18-162665
2018-05-1416:26 ETSC 13DOwnership report, active investor0000903423-18-000274
2018-05-1016:22 ET8-K/A9.01 Financial statements and exhibits0001723128-18-000010
2018-05-0911:33 ETS-1/ARegistration statement, amended0001193125-18-157112
2018-05-0710:02 ETS-1Registration statement0001193125-18-153798
2018-05-0707:44 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-18-153558
2018-05-0707:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-153514
2018-04-1316:53 ETS-1/ARegistration statement, amended0001193125-18-116990
2018-03-0917:00 ET10-KAnnual reportPeriod 2017-12-310001723128-18-000005
2018-03-0717:11 ETS-1Registration statement0001193125-18-073686

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.